Cargando…

New Frontiers for the Cytoskeletal Protein LASP1

In the recent two decades, LIM and SH3 protein 1 (LASP1) has been developed from a simple actin-binding structural protein to a tumor biomarker and subsequently to a complex, nuclear transcriptional regulator. Starting with a brief historical perspective, this review will mainly compare and contrast...

Descripción completa

Detalles Bibliográficos
Autores principales:	Butt, Elke, Raman, Dayanidhi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6160563/ https://www.ncbi.nlm.nih.gov/pubmed/30298118 http://dx.doi.org/10.3389/fonc.2018.00391

Ejemplares similares

LASP1 in Cellular Signaling and Gene Expression: More than Just a Cytoskeletal Regulator
por: Butt, Elke, et al.
Publicado: (2022)

The CXCR4-LASP1-eIF4F Axis Promotes Translation of Oncogenic Proteins in Triple-Negative Breast Cancer Cells
por: Howard, Cory M., et al.
Publicado: (2019)

Role of the CXCR4-LASP1 Axis in the Stabilization of Snail1 in Triple-Negative Breast Cancer
por: Subramaniyan, Boopathi, et al.
Publicado: (2020)

Lasp-1 Regulates Podosome Function
por: Stölting, Miriam, et al.
Publicado: (2012)

LASP-1 – A nuclear hub for the UHRF1-DNMT1-G9a-Snail1 complex
por: Duvall-Noelle, Nichole, et al.
Publicado: (2015)

Oridonin Induces Apoptosis in Esophageal Squamous Cell Carcinoma by Inhibiting Cytoskeletal Protein LASP1 and PDLIM1
por: Zhang, Xiaojun, et al.
Publicado: (2023)

The CXCR4-Dependent LASP1-Ago2 Interaction in Triple-Negative Breast Cancer
por: Tilley, Augustus M. C., et al.
Publicado: (2020)

An update on the LIM and SH3 domain protein 1 (LASP1): a versatile structural, signaling, and biomarker protein
por: Orth, Martin F., et al.
Publicado: (2014)

LASP1, a Newly Identified Melanocytic Protein with a Possible Role in Melanin Release, but Not in Melanoma Progression
por: Vaman V. S., Anjana, et al.
Publicado: (2015)

Regulation of matrix metalloproteinases (MMPs) expression and secretion in MDA-MB-231 breast cancer cells by LIM and SH3 protein 1 (LASP1)
por: Endres, Marcel, et al.
Publicado: (2016)

Nuclear localization and cytosolic overexpression of LASP-1 correlates with tumor size and nodal-positivity of human breast carcinoma
por: Grunewald, Thomas GP, et al.
Publicado: (2007)

Knockout of LASP1 in CXCR4 expressing CML cells promotes cell persistence, proliferation and TKI resistance
por: Herrmann, Andreas B., et al.
Publicado: (2020)

The MYH9 Cytoskeletal Protein Is a Novel Corepressor of Androgen Receptors
por: Liu, Chunhua, et al.
Publicado: (2021)

Loss of tumor suppressor mir-203 mediates overexpression of LIM and SH3 Protein 1 (LASP1) in high-risk prostate cancer thereby increasing cell proliferation and migration
por: Hailer, Amelie, et al.
Publicado: (2014)

Editorial: Drug resistance in breast cancer – mechanisms and approaches to overcome chemoresistance
por: Raman, Dayanidhi, et al.
Publicado: (2023)

Lasp1 Expression Is Implicated in Embryonic Development of Zebrafish
por: Grossi, Ilaria, et al.
Publicado: (2022)

Phosphorylation-Dependent Differences in CXCR4-LASP1-AKT1 Interaction between Breast Cancer and Chronic Myeloid Leukemia
por: Butt, Elke, et al.
Publicado: (2020)

Nuclear localisation of LASP-1 correlates with poor long-term survival in female breast cancer
por: Frietsch, J J, et al.
Publicado: (2010)

LASP1 is a novel BCR-ABL substrate and a phosphorylation-dependent binding partner of CRKL in chronic myeloid leukemia
por: Frietsch, Jochen J., et al.
Publicado: (2014)

Editorial: The Role of Breast Cancer Stem Cells in Clinical Outcomes
por: Raman, Dayanidhi, et al.
Publicado: (2020)

Overexpression of LASP-1 mediates migration and proliferation of human ovarian cancer cells and influences zyxin localisation
por: Grunewald, T G P, et al.
Publicado: (2007)

Lasp brings a giant down to size
por: Short, Ben
Publicado: (2014)

Bioinformatics analysis of the proteins interacting with LASP-1 and their association with HBV-related hepatocellular carcinoma
por: Kong, Fan-Yun, et al.
Publicado: (2017)

Therapeutic Targeting of Alternative Splicing: A New Frontier in Cancer Treatment
por: Murphy, Anthony J., et al.
Publicado: (2022)

CircRNAs in Malignant Tumor Radiation: The New Frontier as Radiotherapy Biomarkers
por: Wu, Xixi, et al.
Publicado: (2022)

Editorial: New frontiers in “bladder sparing” treatments for high risk NMIBC
por: Hurle, Rodolfo, et al.
Publicado: (2023)

Investigating lasp-2 in cell adhesion: new binding partners and roles in motility
por: Bliss, Katherine T., et al.
Publicado: (2013)

Beyond PD-1: The Next Frontier for Immunotherapy in Melanoma
por: Rohatgi, Anjali, et al.
Publicado: (2021)

Regulation of cell migration and survival by focal adhesion targeting of Lasp-1
por: Lin, Yi Hsing, et al.
Publicado: (2004)

LASP Test Board cooling simulations - first approach
por: Zayed, Mohamed
Publicado: (2019)

Frontiers in Bladder Cancer Genomic Research
por: Li, Yi, et al.
Publicado: (2021)

The nebulin repeat protein Lasp regulates I-band architecture and filament spacing in myofibrils
por: Fernandes, Isabelle, et al.
Publicado: (2014)

Silencing of LIM and SH3 Protein 1 (LASP-1) Inhibits Thyroid Cancer Cell Proliferation and Invasion
por: Gao, Wei, et al.
Publicado: (2017)

LIM and SH3 protein 1 (LASP1) differentiates malignant chordomas from less malignant chondrosarcomas
por: Vanderheijden, Cas, et al.
Publicado: (2022)

Lasp1 regulates adherens junction dynamics and fibroblast transformation in destructive arthritis
por: Beckmann, Denise, et al.
Publicado: (2021)

Current and Future Frontiers of Molecularly Defined Oligodendrogliomas
por: Rincon-Torroella, Jordina, et al.
Publicado: (2022)

Novel and Alternative Targets Against Breast Cancer Stemness to Combat Chemoresistance
por: Sridharan, Sangita, et al.
Publicado: (2019)

Molecular characterization of LASP-1 expression reveals vimentin as its new partner in human hepatocellular carcinoma cells
por: SALVI, ALESSANDRO, et al.
Publicado: (2015)

Polymorphism in the LASP1 gene promoter region alters cognitive functions of patients with schizophrenia
por: Lin, Chieh-Hsin, et al.
Publicado: (2019)

Targeting of the Eukaryotic Translation Initiation Factor 4A Against Breast Cancer Stemness
por: Sridharan, Sangita, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_54psk5kp8bl3mnu81813q6mb4l